Obalon Therapeutics, Inc. (NASDAQ:OBLN) shares shot up 485% to $9.42 after the company announced a merger agreement with ReShape Lifesciences.
Off course these spikes are insider trading.
A stock that spikes from a LOW of 1.56 to 10.77 within a day was prepared even on pre market hours. The company announced a merger with ReShape Lifescience. Betting on higher payouts they started buying. Buy at 2.00 and sell at $9.00?
Run a $3,000 for 1,500 shares and sell them for a 7 Dollar profit. Cash in $10,500.
Who else missed it?